Company intelligence / Profile preview

Innosiamo

Allschwil, Basel-Landschaft, Switzerlandlinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Innosiamo AG is a Swiss-based life sciences company listed as an active member of the Swiss Biotech Association and as an attendee at major industry events such as Swiss Biotech Day 2025. The company is headquartered in Switzerland, but there are no publicly available details about its specific therapeutic focus, pipeline, or clinical results. No evidence was found of acquisition or closure.

Industry: Biotech

Beyond the preview

Go deeper on Innosiamo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innosiamo.

Explore the full profile